Recap: Rigel Pharmaceuticals Q1 Earnings

Rigel Pharmaceuticals RIGL reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Rigel Pharmaceuticals missed estimated earnings by 14.29%, reporting an EPS of $-0.16 versus an estimate of $-0.14.

Revenue was down $64.28 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 21.12% increase in the share price the next day.

Here's a look at Rigel Pharmaceuticals's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.13 -0.10 -0.11
EPS Actual -0.11 -0.12 -0.08 0.22
Revenue Estimate 21.90M 23.56M 20.37M 31.05M
Revenue Actual 20.41M 21.54M 26.27M 81.02M

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.13 -0.10 -0.11
EPS Actual -0.11 -0.12 -0.08 0.22
Revenue Estimate 21.90M 23.56M 20.37M 31.05M
Revenue Actual 20.41M 21.54M 26.27M 81.02M

To track all earnings releases for Rigel Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings